Centogene (CNTG) News Today → Top Project Outperforms BTC in 2023… (From Crypto 101 Media) (Ad) Free CNTG Stock Alerts $0.71 +0.02 (+2.90%) (As of 03/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCentogene (NASDAQ: CNTG)fool.com - March 22 at 4:09 AMCENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disordersglobenewswire.com - March 19 at 6:30 AMCentogene NV: CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRa Deficiencyfinanznachrichten.de - March 1 at 6:30 AMCENTOGENE scopre la carenza del recettore alfa delle cellule pre-Tit.investing.com - February 29 at 10:42 PMCENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiencyglobenewswire.com - February 29 at 5:00 PMCentogene NV: CENTOGENE Explores Strategic Alternativesfinanznachrichten.de - February 28 at 9:58 AMCentogene NV: CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearingfinanznachrichten.de - February 28 at 9:58 AMCentogene Explores Strategic Alternatives, Incl. Salemarkets.businessinsider.com - February 28 at 9:58 AMCentogene Announces Receipt Of Nasdaq Notice Of Delistingmarkets.businessinsider.com - February 28 at 9:58 AMCentogene to explores strategic alternatives, gets Nasdaq delisting notice; shares plungemsn.com - February 28 at 9:58 AMCENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearingglobenewswire.com - February 28 at 6:30 AMCENTOGENE Explores Strategic Alternativesglobenewswire.com - February 28 at 6:30 AMCentogene NV: CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaborationfinanznachrichten.de - January 25 at 6:16 PMCENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaborationfinance.yahoo.com - January 25 at 8:14 AMCentogene NV: CENTOGENE Receives French Research Tax Credit Accreditationfinanznachrichten.de - January 24 at 7:56 AMCENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomicsfinance.yahoo.com - January 23 at 8:09 AMCENTOGENE Announces Preliminary Full Year 2023 Revenuefinance.yahoo.com - January 18 at 8:11 AMCentogene NV Ordinary Shares CNTGmorningstar.com - December 21 at 12:43 AMCentogene NV: CENTOGENE's Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestonefinanznachrichten.de - December 13 at 11:46 PMMotus GI, C4 Therapeutics among healthcare moversmsn.com - December 13 at 1:45 PMCCCC, XPOF and AUVI are among pre market gainersmsn.com - December 13 at 8:45 AMCENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestonefinance.yahoo.com - December 13 at 8:45 AMCentogene NV: CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transactionfinanznachrichten.de - November 28 at 12:57 PMCENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transactionfinance.yahoo.com - November 28 at 7:56 AMEVER, BIVI and CNTG among mid-day moversmsn.com - October 31 at 3:42 PMH.C. Wainwright Keeps Their Buy Rating on Centogene NV (CNTG)markets.businessinsider.com - September 15 at 1:53 PMCENTOGENE to Present at H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - September 11 at 5:19 PMCENTOGENE Reports First Half 2023 Financial Resultsbenzinga.com - September 7 at 6:12 PMCentogene NV: CENTOGENE Receives Nasdaq Non-Compliance Notification Regarding Minimum Market Value of Publicly Held Shares Deficiencyfinanznachrichten.de - September 1 at 10:10 AMCENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patientsfinance.yahoo.com - September 1 at 10:10 AMCENTOGENE Receives Nasdaq Non-Compliance Notification Regarding Minimum Market Value of Publicly Held Shares Deficiencyfinance.yahoo.com - August 31 at 7:06 PMCENTOGENE to Participate in Upcoming Conferences in Augustfinance.yahoo.com - August 7 at 8:20 AMCentogene NV: CENTOGENE Regains Compliance With Nasdaq Listing Requirementsfinanznachrichten.de - July 14 at 1:05 PMCentogene NV: CENTOGENE Biodatabank Reveals Unique Genetic Variants in World's Largest Niemann-Pick Type C1 Disease Cohortfinanznachrichten.de - July 12 at 10:09 AMCENTOGENE Biodatabank Reveals Unique Genetic Variants in World's Largest Niemann-Pick Type C1 Disease Cohorttechnews.tmcnet.com - July 12 at 10:09 AMLifera and CENTOGENE, Enter Strategic Collaboration - Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testingfinance.yahoo.com - July 2 at 9:17 AMCentogene NV: CENTOGENE Announces Approval of All Resolutions Tabled at 2023 Annual General Meetingfinanznachrichten.de - July 1 at 8:20 AMCENTOGENE Announces Approval of All Resolutions Tabled at 2023 Annual General Meetingfinance.yahoo.com - June 30 at 8:00 PMHC Wainwright & Co. Reiterates Centogene (CNTG) Buy Recommendationmsn.com - June 28 at 11:50 PMAnalyst Expectations for Centogene's Futuremarkets.businessinsider.com - June 28 at 1:49 PMCNTG Skyrockets after Strategic JV with Liferamsn.com - June 27 at 1:03 PMWhy Centogene (CNTG) Stock Is Roaring Higher Tuesdaymsn.com - June 27 at 1:03 PMmarketbeat.com - June 27 at 7:27 AMCENTOGENE Receives Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares Deficiencyfinance.yahoo.com - June 14 at 7:34 PMHC Wainwright & Co. Maintains Centogene (CNTG) Buy Recommendationmsn.com - May 18 at 4:42 PMThe Latest Analyst Ratings for Centogenemarkets.businessinsider.com - May 18 at 4:42 PMHC Wainwright & Co. Maintains Buy Rating for Centogene: Here's What You Need To Knowmsn.com - May 18 at 4:42 PMCentogene NV: CENTOGENE Reports Full Year 2022 Financial Resultsfinanznachrichten.de - May 17 at 4:09 AMCentogene GAAP EPS of -Є1.19, revenue of Є47.5Mmsn.com - May 17 at 4:09 AMCENTOGENE Reports Full Year 2022 Financial Resultsfinance.yahoo.com - May 16 at 11:08 PM Get Centogene News Delivered to You Automatically Sign up to receive the latest news and ratings for CNTG and its competitors with MarketBeat's FREE daily newsletter. Email Address Did you make $29,000 two days with AI options trades? (Ad)What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below: Click Here To Get Your Free Copy CNTG Media Mentions By Week CNTG Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CNTG News Sentiment▼0.960.61▲Average Medical News Sentiment CNTG News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CNTG Articles This Week▼31▲CNTG Articles Average Week Get Centogene News Delivered to You Automatically Sign up to receive the latest news and ratings for CNTG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PMD News DMTK News BGLC News XGN News OPGN News RNLX News ENZ News XLO News SNTI News BMRA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CNTG) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centogene Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.